Company Search:
Advanced Search
Sponsored Links
Cyxone AB Company Snapshot
Cyxone AB operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cyxone AB with three other pharmaceutical manufacturers in Europe: Irlab Therapeutics Ab (2016 sales of 144,000.00 Swedish Kronor [US$14,882.40 ] ), Elanix Biotechnologies AG of GERMANY (6,226.00 Euros [US$6,789.52 ] ), and Infant Bacterial Therapeutics AB (162,000.00 Swedish Kronor [US$16,742.70 ] ).

Sales Analysis.
  Stock Performance Chart for Cyxone AB
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 4.75
(Figures in Swedish Kronor)
1 Week 20.4%   13 Weeks 30.0%  
4 Weeks 35.1%   52 Weeks 35.7%  
Cyxone AB Key Data:
  Ticker: CYXO Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 21,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 233,131,805
  Fiscal Yr Ends: December Shares Outstanding: 49,080,380
  Share Type: AKTIE Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.